Condor Capital Management Vertex Pharmaceuticals Inc Transaction History

Condor Capital Management

$1.09 Billion
Q3 2024

A detailed history of Condor Capital Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Condor Capital Management holds 6,558 shares of VRTX stock, worth $2.96 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

6,558

Previous 6,599 0.62%

Holding current value

$2.96 Million

Previous $3.09 Million 1.42%

% of portfolio

0.28%

Previous 0.3%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$460.0 - $505.78 $18,860 - $20,736	-41 Reduced 0.62%	6,558 $3.05 Million
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $110,379 - $136,433	-281 Reduced 4.08%	6,599 $3.09 Million
Q1 2024 May 09, 2024	SELL	$407.69 - $446.08 $58,299 - $63,789	-143 Reduced 2.04%	6,880 $2.88 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $25,725 - $30,801	-75 Reduced 1.06%	7,023 $2.86 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $2,367 - $2,537	7 Added 0.1%	7,098 $2.47 Million
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $42,446 - $47,507	-135 Reduced 1.87%	7,091 $2.5 Million
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $1,132 - $1,292	4 Added 0.06%	7,226 $2.28 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $10,287 - $11,573	36 Added 0.5%	7,222 $2.09 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $64,076 - $71,494	-234 Reduced 3.15%	7,186 $2.08 Million
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $30,779 - $38,324	131 Added 1.8%	7,420 $2.09 Million
Q1 2022 May 10, 2022	BUY	$221.42 - $260.97 $719,836 - $848,413	3,251 Added 80.51%	7,289 $1.9 Million
Q4 2021 Feb 09, 2022	SELL	$177.01 - $223.45 $607,675 - $767,103	-3,433 Reduced 45.95%	4,038 $887,000
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $39,724 - $44,454	219 Added 3.02%	7,471 $1.36 Million
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $3,937 - $4,643	-21 Reduced 0.29%	7,252 $1.46 Million
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $1.51 Million - $1.76 Million	7,273 New	7,273 $1.56 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Condor Capital Management with notifications on news.

Account

Condor Capital Management Vertex Pharmaceuticals Inc Transaction History